PNC Financial Services Group
MIRM icon

PNC Financial Services Group’s Mirum Pharmaceuticals MIRM Stock Holding History

PNC Financial Services Group’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$125K Buy
1,356
+744
+122% +$70K ﹤0.01% 2662
2025
Q4 		$48.3K Sell
612
-650
-52% -$46.7K ﹤0.01% 3231
2025
Q3 		$92.5K Buy
1,262
+817
+184% +$51.9K ﹤0.01% 2853
2025
Q2 		$22.6K Sell
445
-8
-2% -$356 ﹤0.01% 3513
2025
Q1 		$20.4K Buy
453
+282
+165% +$13.3K ﹤0.01% 3529
2024
Q4 		$7.07K Sell
171
-52
-23% -$2.17K ﹤0.01% 3923
2024
Q3 		$8.7K Buy
223
+132
+145% +$5.27K ﹤0.01% 3850
2024
Q2 		$3.11K Sell
91
-46
-34% -$1.21K ﹤0.01% 4129
2024
Q1 		$3.44K Buy
137
+96
+234% +$2.64K ﹤0.01% 4062
2023
Q4 		$1.21K Buy
41
+26
+173% +$787 ﹤0.01% 4285
2023
Q3 		$474 Hold
15
– – ﹤0.01% 4468
2023
Q2 		$388 Buy
+15
New +$399 ﹤0.01% 4612
2023
Q1 		– Sell
-18
Closed -$351 – 4772
2022
Q4 		$351 Hold
18
– – ﹤0.01% 4575
2022
Q3 		$0 Hold
18
– – ﹤0.01% 4548
2022
Q2 		$0 Buy
+18
New +$425 ﹤0.01% 4629

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

PNC Financial Services Group's MIRM Position: Q1 2026 in Review

PNC Financial Services Group increased its Mirum Pharmaceuticals (MIRM) stake by 122% in Q1 2026, buying an estimated $70K and bringing the position to 1,356 shares worth $125K. The position accounts for ﹤0.01% of the portfolio, ranked #2662.

PNC Financial Services Group first reported a position in MIRM in Q2 2022 and has held it in 15 quarters since. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • PNC Financial Services Group held 1,356 shares of Mirum Pharmaceuticals worth $125K as of Q1 2026.
  • PNC Financial Services Group bought 744 Mirum Pharmaceuticals shares in Q1 2026, an estimated $70K.
  • Mirum Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #2662 holding.
  • PNC Financial Services Group first reported a position in Mirum Pharmaceuticals in Q2 2022 and has held it in 15 quarters since.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.